Carta Acesso aberto Revisado por pares

Atrial fibrillation—a curable condition?

2002; Oxford University Press; Volume: 23; Issue: 7 Linguagem: Inglês

10.1053/euhj.2001.3016

ISSN

1522-9645

Autores

Carlo Pappone,

Tópico(s)

Antiplatelet Therapy and Cardiovascular Diseases

Resumo

percutaneous intervention vs CABG patients after 1 year and 56% vs 82% after 2 years [13,15] .Therefore, in diabetic patients with multivessel disease amenable to percutaneous intervention the increased rate of major cardiac events in the follow-up period must be emphasized and carefully weighed against the increased perioperative mortality and morbidity.Most patients with multivessel coronary artery disease, including patients with high operative risks, can safely be treated with either percutaneous intervention or CABG.Diabetic patients with multivessel disease are the only group that is better served with CABG in the long-term.The future availability of coated stents may dramatically reduce restenosis rates.Since restenosis is responsible for most repeat interventions in percutaneous intervention patients, this will surely change our practice.If restenosis rates are substantially decreased, percutaneous intervention might become the preferred revascularization technique in all patients with lesions amenable to percutaneous interventions.

Referência(s)
Altmetric
PlumX